Activity ID
13102Expires
March 19, 2027Format Type
EnduringCME Credit
0.5Fee
30CME Provider: American Medical Association
Description of CME Course
Advances in genetic research have allowed us to develop testing, treatment, and prevention strategies based upon patients’ unique genetic characteristics, medical history, and environment. But what happens when patients whose ancestry or ethnicity was not represented in the research dataset are seeking care? This can lead to deepening and concerning health inequities. In this episode, we’ll discuss these health equity concerns in genetic databases and their impact on underrepresented and mixed populations.
Disclaimers
1. This activity is accredited by the American Medical Association.
2. This activity is free to AMA members.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Allergy and Immunology
Anesthesiology
Colon and Rectal Surgery
Family Medicine
Medical Genetics and Genomics
Nuclear Medicine
Ophthalmology
Orthopaedic Surgery
Pathology
Physical Medicine and Rehabilitation
Plastic Surgery
Preventive Medicine
Psychiatry and Neurology
Radiology
Thoracic Surgery
Urology
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
1. Explain how current genetic tests may contribute to health inequities
2. Relate how the effectiveness of a treatment or medication for a patient whose ancestry or ethnicity was not represented in the research can be compromised
3. Describe steps health care professionals can take to demonstrate trustworthiness with historically marginalized groups recruited for genetic testing
Keywords
Equity, Diversity, and Inclusion, Genetics and Genomics
Competencies
Medical Knowledge
CME Credit Type
AMA PRA Category 1 Credit
DOI
10.1001/ama.2022.0003701